How Does Catalyst Pharmaceuticals Inc (CPRX) Stock Compare to Others in Biotechnology?

Tuesday, July 7, 2020 3:29 PM | InvestorsObserver Analysts

Catalyst Pharmaceuticals Inc (CPRX) is around the top of the Biotechnology industry according to InvestorsObserver. CPRX received an overall rating of 70, which means that it scores higher than 70 percent of all stocks. Catalyst Pharmaceuticals Inc also achieved a score of 78 in the Biotechnology industry, putting it above 78 percent of Biotechnology stocks. Biotechnology is ranked 11 out of the 148 industries.

Overall Score - 70
CPRX has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on CPRX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Catalyst Pharmaceuticals Inc Stock Today?

Catalyst Pharmaceuticals Inc (CPRX) stock has risen 2.14% while the S&P 500 is down -0.7% as of 3:26 PM on Tuesday, Jul 7. CPRX is up $0.11 from the previous closing price of $4.90 on volume of 1,016,716 shares. Over the past year the S&P 500 is higher by 6.10% while CPRX is up 27.16%. CPRX earned $0.40 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 12.42.

To see the top 5 stocks in Biotechnology click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

European ADRs Edge Lower in Monday Trading

Should You Buy Pacific Biosciences of California Inc (PACB) Stock on Monday?

Is Fennec Pharmaceuticals Inc (FENC) Stock About to Get Hot Monday?

Do Traders View Akers Biosciences Inc (AKER) Stock's Current Trend Positively?

Will T2 Biosystems Inc (TTOO) Beat the Rest of the Stocks in the Healthcare Sector?

Related Companies